Is anti-HCV blood donor screening useful?

Grouping of PFAS for human health risk assessment: Findings from an independent panel of experts.

Regulatory toxicology and pharmacology : RTP·2022

PSMA PET/CT with Glu-urea-Lys-(Ahx)-[⁶⁸Ga(HBED-CC)] versus 3D CT volumetric lymph node assessment in recurrent prostate cancer.

European journal of nuclear medicine and molecular imaging·2015

Emission factors for PCDD/PCDF and dl-PCB from open burning of biomass.

Environment international·2011

Emissions of PCDD and PCDF from combustion of forest fuels and sugarcane: a comparison between field measurements and simulations in a laboratory burn facility.

Chemosphere·2011

Time course transcriptomics of IFNB1b drug therapy in multiple sclerosis.

Autoimmunity·2009

United Nations Environment Programme Capacity Building Pilot Project--training and interlaboratory study on persistent organic pollutant analysis under the Stockholm Convention.

Analytica chimica acta·2008

Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.

Lancet (London, England)·2026

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Living With Acquired Haemophilia: Patients' and Relatives' Experiences - A Single-Centre Study.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·2026

Acute heparin-induced thrombocytopenia following aortic dissection repair with platelet count recovery and anti-platelet factor 4/heparin antibody seroreversion despite ongoing device-related heparin exposure.

Haematologica·2026

Rare inherited coagulation disorders and thrombosis.

Haematologica·2026

Coronary-Driven Cerebral Revascularization in Type 2a Takayasu Arteritis: A Rare Multisystem Collateral Phenotype.

Cureus·2026

Severe Secondary Haemophagocytic Lymphohistiocytosis Syndrome Due to Crimean-Congo Haemorrhagic Fever Virus: Thinking out of the Box.

European journal of case reports in internal medicine·2026

Comparison of the efficacy and safety of nafamostat mesylate and heparin in blood purification therapy for patients with severe acute pancreatitis: protocol for a randomized controlled trial.

Frontiers in medicine·2026

Related Experiment Videos

Is anti-HCV blood donor screening useful?

Related Concept Videos

Grouping of PFAS for human health risk assessment: Findings from an independent panel of experts.

PSMA PET/CT with Glu-urea-Lys-(Ahx)-[⁶⁸Ga(HBED-CC)] versus 3D CT volumetric lymph node assessment in recurrent prostate cancer.

Emission factors for PCDD/PCDF and dl-PCB from open burning of biomass.

Emissions of PCDD and PCDF from combustion of forest fuels and sugarcane: a comparison between field measurements and simulations in a laboratory burn facility.

Time course transcriptomics of IFNB1b drug therapy in multiple sclerosis.

United Nations Environment Programme Capacity Building Pilot Project--training and interlaboratory study on persistent organic pollutant analysis under the Stockholm Convention.

Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

Living With Acquired Haemophilia: Patients' and Relatives' Experiences - A Single-Centre Study.

Acute heparin-induced thrombocytopenia following aortic dissection repair with platelet count recovery and anti-platelet factor 4/heparin antibody seroreversion despite ongoing device-related heparin exposure.

Rare inherited coagulation disorders and thrombosis.

Coronary-Driven Cerebral Revascularization in Type 2a Takayasu Arteritis: A Rare Multisystem Collateral Phenotype.

Severe Secondary Haemophagocytic Lymphohistiocytosis Syndrome Due to Crimean-Congo Haemorrhagic Fever Virus: Thinking out of the Box.

Comparison of the efficacy and safety of nafamostat mesylate and heparin in blood purification therapy for patients with severe acute pancreatitis: protocol for a randomized controlled trial.

Related Experiment Videos

Is anti-HCV blood donor screening useful?

Related Concept Videos

Related Articles